RNAi screens identify CHD4 as an essential gene in breast cancer growth

Carolina D'Alesio1, Simona Punzi1, Angelo Cicalese1

  • 1Department of Experimental Oncology, European Institute of Oncology, Milan 20141, Italy.

Oncotarget
|October 26, 2016
PubMed

Insights

Genetic screens identified Chromodomain Helicase DNA binding Protein 4 (CHD4) as a key driver of breast cancer growth. Silencing CHD4 inhibited tumor proliferation and progression, suggesting it as a potential therapeutic target for breast cancer.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Epigenetic regulation is crucial in tumor development.
  • Epigenetic modifiers are promising drug targets for cancer therapy.
  • Identifying novel breast cancer vulnerabilities can improve patient outcomes.

Purpose of the Study:

  • To identify new therapeutic targets for breast cancer by screening epigenetic modifiers.
  • To investigate the role of Chromodomain Helicase DNA binding Protein 4 (CHD4) in breast cancer tumorigenesis.

Main Methods:

  • Conducted in vivo and in vitro shRNA screens using epigenetic libraries in a human breast cancer cell model (MCF10DCIS.com).
  • Investigated the function of CHD4 in breast cancer using various in vivo models, including spontaneous mouse models (MMTV-NeuT) and patient-derived xenografts.
  • Analyzed cell cycle progression and gene expression changes upon CHD4 depletion.

Main Results:

  • CHD4 silencing significantly reduced tumor growth in vivo and proliferation in vitro in breast cancer models.
  • CHD4 depletion did not affect the proliferation of non-transformed mammary epithelial cells (MCF10A).
  • CHD4 depletion induced a G0/G1 cell cycle arrest, associated with increased CDKN1A (p21) expression.

Conclusions:

  • Genetic screens are effective in identifying tumor vulnerabilities.
  • CHD4 plays a critical role in breast cancer progression.
  • CHD4 inhibition represents a potential therapeutic strategy for breast cancer treatment.

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.2K
Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.8K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.7K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
10.3K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K